Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Münger

Showing results (11-20 of 219) with videos related to

Pageof 22
Sort By:
Biochimica Et Biophysica Acta|May 9, 2001
Centrosome abnormalities, genomic instability and carcinogenic progressionS Duensing, K Münger
Cancer Research|October 8, 2010
Clld7, a candidate tumor suppressor on chromosome 13q14, regulates pathways of DNA damage/repair and apoptosisXiaobo Zhou, Karl Münger
Regional-Anaesthesie|January 1, 1982
[Caudal anaesthesia in children and the danger of seizures. A case report (author's transl)]L Verlic, U Münger
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Human papillomaviruses as therapeutic targets in human cancerKarin Hellner, Karl Münger
Virology|January 13, 2009
Expression of the human papillomavirus type 16 E7 oncoprotein induces an autophagy-related process and sensitizes normal human keratinocytes to cell death in response to growth factor deprivationXiaobo Zhou, Karl Münger
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Human papillomaviruses and associated malignanciesR M Alani, K Münger
Oncogene|May 25, 2004
Depletion of physiological levels of the human TID1 protein renders cancer cell lines resistant to apoptosis mediated by multiple exogenous stimuliKirsten M Edwards, Karl Münger
Oncogene|May 4, 2004
Make WARTS, not cancer!Kirsten M Edwards, Karl Münger
Journal of Virology|April 1, 1997
Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoproteinD L Jones, K Münger
Virology|August 23, 2008
Direct association of the HPV16 E7 oncoprotein with cyclin A/CDK2 and cyclin E/CDK2 complexesChristine L Nguyen, Karl Münger
Pageof 22

Showing results (11-20 of 219) with videos related to

Sort By:
Pageof 22
Biochimica Et Biophysica Acta|May 9, 2001
Centrosome abnormalities, genomic instability and carcinogenic progressionS Duensing, K Münger
Cancer Research|October 8, 2010
Clld7, a candidate tumor suppressor on chromosome 13q14, regulates pathways of DNA damage/repair and apoptosisXiaobo Zhou, Karl Münger
Regional-Anaesthesie|January 1, 1982
[Caudal anaesthesia in children and the danger of seizures. A case report (author's transl)]L Verlic, U Münger
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Human papillomaviruses as therapeutic targets in human cancerKarin Hellner, Karl Münger
Virology|January 13, 2009
Expression of the human papillomavirus type 16 E7 oncoprotein induces an autophagy-related process and sensitizes normal human keratinocytes to cell death in response to growth factor deprivationXiaobo Zhou, Karl Münger
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Human papillomaviruses and associated malignanciesR M Alani, K Münger
Oncogene|May 25, 2004
Depletion of physiological levels of the human TID1 protein renders cancer cell lines resistant to apoptosis mediated by multiple exogenous stimuliKirsten M Edwards, Karl Münger
Oncogene|May 4, 2004
Make WARTS, not cancer!Kirsten M Edwards, Karl Münger
Journal of Virology|April 1, 1997
Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoproteinD L Jones, K Münger
Virology|August 23, 2008
Direct association of the HPV16 E7 oncoprotein with cyclin A/CDK2 and cyclin E/CDK2 complexesChristine L Nguyen, Karl Münger
Pageof 22